Mosleh, B., Schelch, K., Mohr, T., Klikovits, T., Wagner, C., Ratzinger, L. ... Grusch, M. (2023). Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis. Thoracic Cancer, 14. (22), 2177-2186. doi: 10.1111/1759-7714.15004
Mosleh, Berta, et al. "Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis." Thoracic Cancer, vol. 14, no. 22, 2023, pp. 2177-2186. https://doi.org/10.1111/1759-7714.15004
Mosleh, Berta, Karin Schelch, Thomas Mohr, Thomas Klikovits, Christina Wagner, Lukas Ratzinger, Yawen Dong, et al. "Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis." Thoracic Cancer 14, no. 22 (2023): 2177-2186. https://doi.org/10.1111/1759-7714.15004
Mosleh, B., et al. (2023) 'Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis', Thoracic Cancer, 14(22), pp. 2177-2186. doi: 10.1111/1759-7714.15004
Mosleh B, Schelch K, Mohr T, Klikovits T, Wagner C, Ratzinger L, and sur.. Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis. Thoracic Cancer [Internet]. 2023 June 21 [cited 2024 August 16];14(22):2177-2186. doi: 10.1111/1759-7714.15004
B. Mosleh, et al., "Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis", Thoracic Cancer, vol. 14, no. 22, pp. 2177-2186, June 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:778143. [Accessed: 16 August 2024]